US FDA approves Medtronic's medical device for Parkinson's disease
The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with ...
2 Very Healthy High-Yield Dividend Stocks to Buy for a Safe and Growing Passive Income Stream
A higher dividend yield is nice because it allows you to collect more dividend income on every dollar you invest in a stock.
FierceBiotech1h
FDA approves Medtronic’s adaptive deep-brain stimulator for Parkinson’s disease
Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the ...
MassDevice1h
Medtronic wins first FDA nod for adaptive DBS for Parkinson’s
(NYSE: MDT) announced today that the FDA approved its BrainSense adaptive deep brain stimulation (aDBS) platform.
Medtronic's deep brain stimulation system for Parkinson's disease wins FDA nod
Medtronic's FDA-approved BrainSense Adaptive DBS system revolutionizes Parkinson's therapy with real-time adjustments for ...
Medtronic’s BrainSense brain stimulation system approved by FDA for Parkinson’s
Medtronic (MDT) announced FDA approval of BrainSense Adaptive deep brain stimulation – aDBS – and BrainSense Electrode Identifier. There is no ...
Medtronic Parkinson's Disease Brain Stimulation System Gets FDA Approval
Medtronic said the Food and Drug Administration approved a brain stimulation system for people afflicted with Parkinson's disease.
Medtronic plc: Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's
New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever ...
Amgen opens new technology & innovation site in Hyderabad, to invest $200 million
The site is expected to accelerate Amgen’s digital capabilities through artificial intelligence and data science to further ...